John A. Way's most recent trade in Proto Labs Inc was a trade of 4,433 Common Stock done . Disclosure was reported to the exchange on Feb. 16, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Proto Labs Inc | John A. Way | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 4,433 | 33,657 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | John A. Way | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 3,128 | 3,128 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | John A. Way | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 197.05 per share. | 16 Feb 2021 | 2,171 | 29,224 (0%) | 0% | 197.1 | 427,796 | Common Stock |